Beroni Logo @ Dec 2019.png
Beroni Group Received a US$1.07 Million Order for COVID-19 Antigen Test Kits from Japan
18 nov. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Group Published an Article Related to Single-Domain Antibodies in the FEBS Journal
28 oct. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Oct. 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based biopharmaceutical enterprise, today announced...
Beroni Logo @ Dec 2019.png
Beroni Group Received Approval for 43.5% R&D Rebate from Australian Government for the Novel, Potential Anti-Cancer Drug PENAO
09 sept. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty...
Beroni Logo @ Dec 2019.png
Beroni Group Announced the Latest Clinical Study of its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method)
31 août 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based biopharmaceutical enterprise, announced the latest clinical...
Beroni Logo @ Dec 2019.png
Beroni Initiates Manufacture of its Novel, Potential Anti-Cancer Drug PENAO
18 août 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise, announced that PENAO...
Beroni Logo @ Dec 2019.png
Beroni Group Signs MoU with tella, Inc to Collaborate in Immunotherapy for Cancer Treatment
28 mai 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Beroni Logo @ Dec 2019.png
Beroni Group Issues US$2 Million of Convertible Notes to Fund Research and Development Plans
28 mai 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 28, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise today...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Has Received Export Permit
27 avr. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 27, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise...
Beroni Logo @ Dec 2019.png
Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
03 févr. 2021 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified biopharmaceutical enterprise today announces...
Beroni Logo @ Dec 2019.png
Beroni Group’s SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) Received CE Certification
21 déc. 2020 08h30 HE | Beroni Group Limited
NEW YORK and SYDNEY, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an Australia-based diversified biopharmaceutical enterprise focused on the...